Skip to Main Content

Your Site Was Selected. So What’s Slowing Down Your Clinical Trial Start-up?

Contributor Spotlight

The insights below are based on a Medix Coffee Chat featuring Jennifer Stanford, MSN, Practice Director of Clinical Site Solutions and Consulting at Medix. Drawing on 30 years of site-level clinical research experience, Jennifer has seen how academic medical centers, health systems, and research sites navigate budget negotiations, regulatory reviews, and operational challenges that affect study activation.


Getting selected as a clinical trial site is an exciting win until you realize you’re still three to six months away from screening your first patient.

It’s a familiar, frustrating scene: the contract is parked with legal, finance is waiting on a revised budget template, and the research team is juggling a complex regulatory submission while managing three active oncology trials. Everyone is working, but nobody owns the master clock.

In clinical research, a stalled trial isn’t just an administrative hassle; it has real enrollment consequences. 

To unpack why site start-ups stall and how to pick up the pace, Medix recruiter Belle Riley sat down with Jennifer Stanford for a Coffee Chat on clinical trial start-up. Drawing on 30 years in site-level operations, Jennifer shared what it takes to compress the path from selection to activation into a focused 90-day sprint for academic medical centers (AMCs) and larger health systems. With this model, individual sites or site networks with fewer approval layers can typically be up and running in 45 days or less.

Where Do the Biggest Delays Happen Between Site Selection and Activation?

Typically there are two challenges at the root cause of start-up delays: budgets and contracts. That’s because both rely on cross-functional teams with competing priorities. A single question requiring input from another department can languish in an inbox for weeks without dedicated follow-up.

At an AMC or large health system, even a study with a finalized budget can stall while legal reviews the contract and radiology confirms it can support the protocol. When those reviews run on different timelines, a delay in any one of them can push back activation.

Even when a trial uses a central institutional review board (IRB), local reliance agreements, and institutional sign-offs still take time. 

Here are the two practices that can reduce preventable delays during these reviews:

  • Surface reliance steps and typical bottlenecks early: Identify local submission requirements on day one and assemble a comprehensive packet up front so reviewers have fewer reasons to send it back with questions.
  • Conduct a rigorous first read of the protocol: Scrutinize the schedule of events for specialized diagnostic imaging, non-standard lab draws, or niche equipment needs. Flagging these items immediately gives you lead time to engage departmental managers before contract terms are locked.

The stakes are particularly high for competitively enrolling trials, where sponsors may close enrollment once recruitment targets are met. Jennifer emphasized:

“The sooner you get it up and running, the sooner you can start enrolling which means the more time you have to capitalize on that enrollment window.”

What Does an Embedded Start-up Expert Do?

Urgency raises another question: Who’s responsible for coordinating all the people and processes involved in getting a study activated? And Jennifer has a name for that person.

“Things get lost in the shuffle when you don’t have what I call a quarterback.” 

An embedded start-up lead keeps track of who owns each milestone, follows up on open questions, and connects the people who can resolve them.

Through Medix Life Sciences Project Solutions, and specifically co-managed services, clinical research sites can bring in a dedicated start-up expert who works alongside their existing team. That expert can help build the study budget, coordinate contract and regulatory milestones, and follow up when decisions are overdue. The site’s existing teams retain final approval responsibilities.

An embedded specialist doesn’t replace existing decision-makers. Finance may still approve final budget numbers, legal will confirm contractual terms, and the Principal Investigator (PI) retains regulatory oversight. The start-up lead’s role is to ensure those stakeholders have what they need to act without delay.

We often recommend an approach to our clients that establishes momentum on day one:

  1. Host an operational kickoff meeting: Bring site leadership, departmental reviewers, and key sponsor or contract research organization (CRO) contacts together to establish shared expectations
  2. Assign clear milestone ownership: Clarify exactly who owns each deliverable, when it’s due, and when a delay should be escalated
  3. Run regular roadblock check-ins: Keep standing meetings focused strictly on what is currently blocked, which review cycle is stalling, and who has the authority to resolve it

Dedicated focus makes the biggest difference. When a Clinical Research Coordinator (CRC) plans to review a Medicare coverage analysis (MCA) in the morning, an urgent adverse event or an unscheduled patient visit will understandably take priority. An embedded start-up specialist protects that momentum, keeping budgets and contracts moving while clinic staff focus on patient care and active protocols.

What Does a 90-Day Activation Plan Look Like?

The same core milestones apply across site types. For independent sites and site networks with fewer approval layers, these milestones may fit into a roughly 45-day plan. For AMCs and large health systems, the example below shows how to spread the same work across three 30-day phases. The goal is to give each phase clear priorities while allowing workstreams to progress simultaneously wherever possible.

  • Days 1–30: Protocol breakdown and initial routing. Read the protocol thoroughly to flag specialized ancillary requirements. Route the clinical trial agreement (CTA) for legal review, build the budget and Medicare coverage analysis concurrently, and submit initial packets for IRB review or local reliance.
  • Days 31–60: Resolution and clinical preparation. Resolve sponsor budget redlines and legal terms. Collect essential regulatory documents, including FDA Form 1572, financial disclosures, and current CVs, while initiating study setup in the clinical trial management system (CTMS). Brief coordinators on protocol workflows so recruitment prep begins well before activation.
  • Days 61–90: Final execution and initiation. Finalize sign-offs on the contract and budget, confirm full IRB approval with approved informed consent forms (ICFs), and verify that all lab kits, investigational product (IP), and study equipment have arrived. Host the site initiation visit (SIV) and complete all delegation-of-authority and training logs before study launch.

And while the timeline provides a useful framework, Jennifer has some advice on where to begin:

“The budget and contract should both be started within that first week because finalizing those can be the slowest piece within start-up.”

CTMS setup is another area where specialized work can affect activation timelines. Building protocol calendars requires teams to translate visit schedules, procedures, and billing requirements into the system. When coordinators are already managing active studies, these builds can compete with patient-facing responsibilities. Dedicated clinical trial calendar build support can help address that workload and reduce configuration backlogs.

Tracking milestone progress across these phases also generates valuable operational data. If every study stalls at coverage analysis or budget sign-off, that points to an internal workflow that needs restructuring. If delays only happen during sudden surges, site leadership knows it’s a team capacity issue rather than a broken process.

Of course, reaching activation is only one milestone. Research teams also need the staffing, documentation, and clinical workflows in place to begin screening patients once the study opens.

How Can Sites Be Ready to Recruit When They Activate?

Activation starts the recruitment window. Stanford recommends making sure coordinators are prepared with a study packet and a protocol-specific checklist for the first visit. 

“I really think having a start-up packet ready that the team reviews together, before they start enrolling, is really critical to getting off on the right foot.”

To make that happen, clinical research teams should begin preparing for the operational handoff weeks before the SIV by focusing on three priorities:

  • Clarify clinical coverage: Assign a lead CRC along with any additional team members, such as a study-specific recruiter or data entry specialist, and designate trained backup coverage early
  • Organize study systems and documentation: Ensure current approved ICFs, source documents, and study specific procedural checklists are accessible to the entire clinical team from day one
  • Equip coordinators with visit checklists: Arm coordinators with protocol-specific checklists detailing visit windows, lab draw timing, and diagnostic orders, especially when they manage multiple complex protocols simultaneously

A seamless operational handoff ensures that once the sponsor issues the formal site activation notice, the team is prepared to begin consenting participants without unnecessary delays.

How Can Research Leaders Reduce Start-up Delays? 

There’s a practical place to begin: Review your recent study start-ups and identify where approvals, handoffs, or resource constraints created avoidable delays.

Start by walking through your site’s three most recent study start-ups. Where did drafts sit untouched? Who had the authority to push them forward? What information would have helped them resolve bottlenecks faster?

Those operational insights show whether your site needs clearer interdepartmental handoffs or dedicated expertise to manage the start-up sprint.

Whether you’re expanding a clinical research enterprise or working through a sudden portfolio backlog, Medix offers clinical research staffing and consulting solutions that embed experienced clinical research professionals alongside your existing team. From research coordinators and regulatory specialists to dedicated start-up experts, we help can help you navigate staffing gaps, reduce site-level administrative strain, and address the operational bottlenecks that delay study activation.

Build Startup Momentum That Lasts

FAQs About Clinical Trial Site Start-up

Budget and contract negotiations are among the most common drivers of start-up delays. However, the underlying issue is often limited capacity across the financial, regulatory, and clinical teams responsible for approvals. Because these documents require input from separate departments balancing multiple responsibilities, redlines frequently stall without dedicated tracking and follow-up.

A clinical trial management system (CTMS) helps research organizations manage study data, workflows, and operational oversight. However, when organizations are implementing or migrating to a new CTMS, limited technical expertise, competing staff priorities, and configuration backlogs can delay study setup. Dedicated CTMS analysts and project support can help address these challenges. Learn more about CTMS implementation staffing solutions.

Protocol calendar builds translate study requirements into visit schedules, procedures, and billing workflows within the CTMS. Inaccurate or delayed builds can create downstream challenges for financial compliance and clinical operations. Assigning experienced calendar builders helps sites manage these specialized tasks while protecting coordinator availability for patient-facing responsibilities. Explore how specialized staffing supports clinical trial calendar builds.

In competitive enrollment studies, sponsors set global or regional recruitment caps. Sites that activate within a 90-day window start screening candidates immediately, while sites caught in extended review cycles often open when available participant slots are nearly full.

An embedded start-up specialist acts as an operational project manager for the trial launch. They build budgets, develop coverage analyses, submit and monitor IRB submissions, and liaise directly with sponsors and CROs so that site-level clinicians can stay focused on active protocols and participant care.

Coordinators should be brought into the workflow around the midpoint of startup (typically Days 31–60). Reviewing protocol workflows, consent forms, and CTMS builds before the Site Initiation Visit ensures the team is prepared to identify and recruit eligible participants immediately upon activation.

Background Image

Work with a Trusted Healthcare and Life Sciences Staffing Partner

Connect with Medix to get the expertise and resources you need to succeed.

Contact us now